Literature DB >> 29752954

Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function.

Nikolaos Perakakis1, Jagriti Upadhyay2, Wael Ghaly3, Joyce Chen2, Pavlina Chrysafi2, Athanasios D Anastasilakis4, Christos S Mantzoros2.   

Abstract

BACKGROUND: We have previously demonstrated that the adipose tissue derived hormone leptin controls reproductive function by regulating the hypothalamic-pituitary-gonadal axis in response to energy deficiency. Here, we evaluate the activins-follistatins-inhibins (AFI) axis during acute (short-term fasting in healthy people) and chronic energy deficiency (women with hypothalamic amenorrhea due to strenuous exercise [HA]) and investigate their relation to leptin and reproductive function in healthy subjects and subjects with HA.
METHODS: The AFI axis was investigated in: a) A double-blinded study in healthy subjects having three randomly assigned admissions, each time for four days: in the isocaloric fed state, complete fasting with placebo treatment, complete fasting with leptin replacement, b) A case-control study comparing women with HA vs healthy controls, c) An open-label interventional study investigating leptin treatment in women with HA over a period of up to three months, d) A randomized interventional trial investigating leptin treatment vs placebo in women with HA for nine months.
RESULTS: The circulating levels of activin A, activin B, follistatin and follistatin-like 3 change robustly in response to acute and chronic energy deficiency. Leptin replacement in acute energy deprivation does not affect the levels of these hormones suggesting an independent regulation by these two hormonal pathways. In chronic energy deficiency, leptin replacement restores only activin B levels, which are in turn associated with an increase in the number of dominant follicles.
CONCLUSIONS: We demonstrate for the first time that the AFI axis is affected both by acute and chronic energy deficiency. Partial restoration of a component of the axis, i.e. activin B only, through leptin replacement is associated with improved reproductive function in women with HA.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute energy deficiency; Chronic energy deficiency; Energy; Fasting; Obesity; PCOS

Mesh:

Substances:

Year:  2018        PMID: 29752954      PMCID: PMC6062472          DOI: 10.1016/j.metabol.2018.05.003

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  33 in total

1.  Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome.

Authors:  R J Norman; C R Milner; N P Groome; D M Robertson
Journal:  Hum Reprod       Date:  2001-04       Impact factor: 6.918

2.  Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women.

Authors:  Anne B Loucks; Jean R Thuma
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

3.  Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.

Authors:  Wouter J K Hehenkamp; Caspar W N Looman; Axel P N Themmen; Frank H de Jong; E R Te Velde; Frank J M Broekmans
Journal:  J Clin Endocrinol Metab       Date:  2006-06-27       Impact factor: 5.958

4.  Recombinant activin A enhances the growth and survival of isolated preantral follicles cultured three-dimensionally in extracellular basement matrix protein (matrigel) under serum-free conditions.

Authors:  Yilmaz Guzel; Gizem Nur Şahin; Mujde Sekeroglu; Alparslan Deniz
Journal:  Gynecol Endocrinol       Date:  2014-03-25       Impact factor: 2.260

5.  Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy.

Authors:  S Muttukrishna; P A Fowler; L George; N P Groome; P G Knight
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

6.  Leptin is an effective treatment for hypothalamic amenorrhea.

Authors:  Sharon H Chou; John P Chamberland; Xiaowen Liu; Giuseppe Matarese; Chuanyun Gao; Rianna Stefanakis; Mary T Brinkoetter; Huizhi Gong; Kalliopi Arampatzi; Christos S Mantzoros
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

7.  Low levels of serum inhibin A and inhibin B in women with hypergonadotropic amenorrhea and evidence of high levels of activin A in women with hypothalamic amenorrhea.

Authors:  F Petraglia; B Hartmann; S Luisi; P Florio; S Kirchengast; M Santuz; A D Genazzani; A R Genazzani
Journal:  Fertil Steril       Date:  1998-11       Impact factor: 7.329

8.  Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers.

Authors:  Helena Teede; Sze Ng; Mark Hedger; Lisa Moran
Journal:  Metabolism       Date:  2013-06-12       Impact factor: 8.694

9.  Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition.

Authors:  Athanasios D Anastasilakis; Stergios A Polyzos; Zacharias G Saridakis; Georgios Kynigopoulos; Elpida C Skouvaklidou; Dimitrios Molyvas; Maria F Vasiloglou; Aggeliki Apostolou; Thomai Karagiozoglou-Lampoudi; Aikaterina Siopi; Vassilis Mougios; Panagiotis Chatzistavridis; Grigorios Panagiotou; Andreas Filippaios; Sideris Delaroudis; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2014-06-10       Impact factor: 5.958

10.  Activin-A promotes the development of goat isolated secondary follicles in vitro.

Authors:  Cleidson Manoel Gomes da Silva; Simone Vieira Castro; Luciana Rocha Faustino; Giovanna Quintino Rodrigues; Ivina Rocha Brito; Rafael Rossetto; Márcia Viviane Alves Saraiva; Claudio Cabral Campello; Carlos Henrique Lobo; Carlos Eduardo Azevedo Souza; Arlindo de Alencar Araripe Moura; Mariana Aragão Matos Donato; Christina Alves Peixoto; José Ricardo de Figueiredo
Journal:  Zygote       Date:  2013-08-13       Impact factor: 1.442

View more
  9 in total

1.  Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.

Authors:  Stergios A Polyzos; Nikolaos Perakakis; Chrysoula Boutari; Jannis Kountouras; Wael Ghaly; Athanasios D Anastasilakis; Asterios Karagiannis; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

Review 2.  GEOFFREY HARRIS PRIZE LECTURE 2018: Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans.

Authors:  Aimilia Eirini Papathanasiou; Eric Nolen-Doerr; Olivia M Farr; Christos S Mantzoros
Journal:  Eur J Endocrinol       Date:  2019-02-01       Impact factor: 6.664

3.  Circulating profile of Activin-Follistatin-Inhibin Axis in women with hypothalamic amenorrhea in response to leptin treatment.

Authors:  Eirini Bouzoni; Nikolaos Perakakis; Christos S Mantzoros
Journal:  Metabolism       Date:  2020-10-10       Impact factor: 8.694

4.  Proteomic alteration of endometrial tissues during secretion in polycystic ovary syndrome may affect endometrial receptivity.

Authors:  Jun Li; Xiaohua Jiang; Caihua Li; Huihui Che; Lin Ling; Zhaolian Wei
Journal:  Clin Proteomics       Date:  2022-05-28       Impact factor: 5.000

5.  Physiology of Activins/Follistatins: Associations With Metabolic and Anthropometric Variables and Response to Exercise.

Authors:  Nikolaos Perakakis; Vassilis Mougios; Ioannis Fatouros; Aikaterina Siopi; Dimitrios Draganidis; Natia Peradze; Wael Ghaly; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

6.  In patients with anorexia nervosa, myokine levels are altered but are not associated with bone mineral density loss and bone turnover alteration.

Authors:  Laurent Maïmoun; Denis Mariano-Goulart; Helena Huguet; Eric Renard; Patrick Lefebvre; Marie-Christine Picot; Anne-Marie Dupuy; Jean-Paul Cristol; Philippe Courtet; Vincent Boudousq; Antoine Avignon; Sébastien Guillaume; Ariane Sultan
Journal:  Endocr Connect       Date:  2022-05-10       Impact factor: 3.221

7.  Different phenotypes and chondrogenic responses of human menstrual blood and bone marrow mesenchymal stem cells to activin A and TGF-β3.

Authors:  Ilona Uzieliene; Edvardas Bagdonas; Kazuto Hoshi; Tomoaki Sakamoto; Atsuhiko Hikita; Zivile Tachtamisevaite; Greta Rakauskiene; Giedrius Kvederas; Ali Mobasheri; Eiva Bernotiene
Journal:  Stem Cell Res Ther       Date:  2021-04-29       Impact factor: 6.832

8.  Effects of Oral Contraception and Lifestyle Modification on Incretins and TGF-ß Superfamily Hormones in PCOS.

Authors:  Aesha Shah; William C Dodson; Penny M Kris-Etherton; Allen R Kunselman; Christy M Stetter; Carol L Gnatuk; Stephanie J Estes; Kelly C Allison; David B Sarwer; Patrick M Sluss; Christos Coutifaris; Anuja Dokras; Richard S Legro
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

9.  Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial.

Authors:  Natia Peradze; Olivia M Farr; Nikolaos Perakakis; Iolanda Lázaro; Aleix Sala-Vila; Christos S Mantzoros
Journal:  Cardiovasc Diabetol       Date:  2019-10-31       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.